OKYO Pharma (OKYO) has been informed that John Brancaccio, Non-Executive Director, has acquired 5,000 of the Company’s ordinary shares on NASDAQ at $1.61, bringing his total holding to 31,201 shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
- Okyo Pharma CDO, director acquire shares
- Okyo Pharma reports results from Phase 2a trial of urcosimod
- OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option
- OKYO Pharma’s Urcosimod NCP Data Selected for Presentation at ARVO 2026